Shao-An Wang

6PUBLICATIONS
21CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 16, 2024
USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy.

Ming-Jer Young, Shao-An Wang, Yung-Ching Chen

|Jan 29, 2024
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo.

Sachin Sharma, Shao-An Wang, Wen-Bin Yang

|Aug 26, 2022
Home Dust Mites Promote MUC5AC Hyper-Expression by Modulating the sNASP/TRAF6 Axis in the Airway Epithelium.

Ming-Zhen Chen, Shao-An Wang, Shih-Chang Hsu

|Apr 13, 2021
USP24 promotes drug resistance during cancer therapy.

Shao-An Wang, Ming-Jer Young, Yi-Chang Wang

Pageof 1